Upstate
Chiropractic
22 E. Genesee St.
Baldwinsville, NY 13027
315-635-2333
|
CDC Plans For Mass Vaccination Of All Children With AIDS Vaccine In
a February 12, 1997 meeting of the CDC's Advisory Committee on Immunization
Practices (ACIP), Neal Halsey, M.D., chairman of the American Academy
of Pediatrics (AAP) Committee on Infectious Diseases, AAP liaison
member of the ACIP and Director of the Institute of Vaccine Safety
at John's Hopkins University, reminded HIV vaccine researchers and
developers at the meeting that the CDC plans to target 11 to 12
year old children for "universal application" of an HIV
vaccine. Halsey told them: "One
of the things that's happened in the past with vaccines is that
sometimes the manufacturers have developed them and tested them
primarily in an age group or a population which may not be the final
target population that this committee has considered. Over the last
few years we have developed a statement on adolescent immunization
and it probably would be worth your reading that, and others, because
we really see age 11 to 12 as the target age for introduction of
vaccines for prevention of sexually transmitted diseases. And I
know that, at this time, you are really studying adults and you're
also some distance away from the actual - having a [HIV] vaccine
in hand that might be licensed and approved - but at least it would
be nice if there were studies that were planned in parallel when
you move another step in the direction of actually having a candidate
vaccine, realizing where WE think we would want to use universal
application of such a vaccine. And so I think maybe [you should
get] a copy of the adolescent immunization statement." With
the Children's Vaccine Initiative (CVI) and pharmaceutical industry
setting up the mechanism for global mass vaccination of children
and adults, including the creation of national and international
vaccine tracking systems, countries with low HIV rates like the
U.S. and Europe will be forced to use an HIV vaccine in order to
pay for the vaccination of populations in Asia and Africa where
HIV infection rates are skyrocketing. In 1996, HIV vaccine developer
Stanley Plotkin, M.D., of Pasteur Merieux Pharmaceuticals (who developed
the rubella vaccine and has been a vaccine policymaker member of
the AAP Committee on Infectious Disease and AAP liaison member of
the ACIP) explained why mandatory vaccination in rich countries
like the U.S. help deliver vaccines to Third World markets: CDC
Tells Congress About Future Vaccines - In testimony before the
U.S. Senate Committee on Labor and Human Resources in 1997, CDC
official Walter Orenstein, M.D., made a bid to persuade Congress
to reauthorize 288 million dollars for the CDC's Immunization Grant
Program in the $427 million 1998 DHHS budget request for immunization
activities. In a review of the history of vaccination, Dr. Orenstein
recounted that, although almost a century passed between the development
of the smallpox vaccine in 1796 and that of the rabies vaccine in
the 1880's, by the middle of the 20th century there were nearly
two dozen vaccines on the market. Painting
a picture of the future, Orenstein said: "On the horizon are
vaccine technologies that would have been considered science fiction
just a decade ago, but are now reported at scientific meetings.
Snippets of synthetic DNA have worked as experimental vaccines in
animals. Edible plants have been bioengineered to become vaccine
factories....vaccines have been enclosed in microscopic capsules,
permitting them to be released slowly over time..." Orenstein
reminded legislators that "Every day about 11,000 babies are
born in this country. Each of these children starts with immunization
coverage of zero. There is why our responsibility to our Nation's
children never ends; it must be sustained every day of every year....completing
state-based immunization registries is the cornerstone of assuring
disease prevention." Vaccine
Registries To Tag, Track, Force Vaccination - Even though CDC
officials admit that there is already a 96 percent vaccination rate
in the U.S. with federally recommended vaccines, they are setting
up state vaccine tracking registries and plan to link them together
to create a de facto national electronic tracking system to ensure
mass compliance with federal vaccine policies. Citizens will be
tagged with a number at birth and tracked even when moving from
state to state. In
1995, DHHS Secretary Donna Shalala appropriated the social security
numbers assigned to newborns to allow states to enter all babies
in state vaccine tracking systems. In 1996, the Health Insurance
Portability and Accountability Act (HIPAA), also known as the Kennedy-Kassebaum
legislation, outlined plans for a "unique health care identifier"
number, which is an alternative to the social security number, to
be assigned to citizens at birth and electronically monitor their
medical records, including vaccination records. In
a 1998 CDC publication entitled Initiative on Immunization Registries,
the CDC states that "we see [vaccine] registries as a possible
first step in the development of an electronic pediatric record"
and "computerized registries will eventually be capable of
capturing immunization for individuals of all ages" and "until
a unique personal identifier can be established on a national basis,
multiple means of identification must be used [in state vaccine
registries]." Core data that is now collected in many state
vaccine tracking systems include a citizen's name, address, phone
number, social security number, birth date, sex, race, primary language,
patient birth order, patient birth registration number, patient
Medicaid number, mother's name (including maiden name) and social
security number and father's name and social security number.
More
on vaccines: Adverse
effects of adjuvants in vaccines Click here
to download this complete article that includes all of the above
listed sub articles. This document is approximately 150 pages (1.24
mg's) and it is in Adobe PDF format. If you do not have a copy of
Adobe Acrobat PDF reader, please download a free copy here.
|
|
|
|
|
|
